PhoenixBio Co., Ltd., Higashi-Hiroshima, Hiroshima, Japan.
Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
PLoS One. 2020 Sep 11;15(9):e0237809. doi: 10.1371/journal.pone.0237809. eCollection 2020.
Chimeric mice with humanized livers are considered a useful animal model for predicting human (h-) drug metabolism and toxicity. In this study, the characteristics of fresh h-hepatocytes (cFHHs, PXB-cells®) isolated from chimeric mice (PXB-mice®) were evaluated in vitro to confirm their utility for drug development. cFHHs cultured at high density (2.13 × 105 cells/cm2) displayed stable production of h-albumin and cytochrome P450 (CYP) 3A activities for at least 21 days. The mRNA expression levels of 10 of 13 CYP, UDP-glucuronosyltransferase (UGT), and transporters were maintained at >10% of the levels of freshly isolated cFHHs after 21 days. From 1 week, many bile canaliculi were observed between cFHHs, and the accumulation of the multidrug resistance-associated protein and bile salt export pump substrates in these bile canaliculi was clearly inhibited by cyclosporin A. Microarray analysis of cFHHs cultured at high density and at low density (0.53 × 105 cells/cm2) revealed that high density culture maintained high expressions of some transcription factors (HNF4α, PXR, and FXR) perhaps involved in the high CYP, UGT and transporter gene expressions of cFHHs. These results strongly suggest that cFHHs could be a novel in vitro tool for drug development studies.
嵌合小鼠具有人源化肝脏,被认为是预测人类(h-)药物代谢和毒性的有用动物模型。在这项研究中,评估了从嵌合小鼠(PXB-小鼠®)中分离的新鲜 h-肝细胞(cFHHs,PXB-cells®)的体外特性,以确认其在药物开发中的应用。高密度(2.13×105 个细胞/cm2)培养的 cFHHs 至少可稳定地产生 h-白蛋白和细胞色素 P450(CYP)3A 活性 21 天。在 21 天后,13 种 CYP、UDP-葡糖醛酸转移酶(UGT)和转运蛋白中的 10 种的 mRNA 表达水平保持在新鲜分离的 cFHHs 水平的>10%。从第 1 周开始,cFHHs 之间观察到许多胆小管,并且环孢素 A 可明显抑制多药耐药相关蛋白和胆汁盐输出泵底物在这些胆小管中的积累。高密度和低密度(0.53×105 个细胞/cm2)培养的 cFHHs 的微阵列分析表明,高密度培养可维持一些转录因子(HNF4α、PXR 和 FXR)的高表达,这些转录因子可能参与 cFHHs 的 CYP、UGT 和转运蛋白高基因表达。这些结果强烈表明 cFHHs 可能成为药物开发研究的新型体外工具。